OTC promotion committee would unlikely trigger disputes in medical community, KMPA says

The Korea Pharmaceutical Manufacturers Association said recently that the business operations of a newly established OTC Promotion Committee, which was harshly criticized from local practitioners, would not undermine the intrinsic rights of doctors and pharmacists with no possible disputes between them.

According to the KPMA, the formation of the controversial committee is designed to better...